Exercise for Cancer Patients at High Risk of Falls

Recruiting in Palo Alto (17 mi)

Overseen ByAminah Jatoi, M.D.

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Phase 1

Waitlist Available

Sponsor: Mayo Clinic

No Placebo Group

Trial Summary

What is the purpose of this trial?Falls are common and catastrophic in cancer patients. Cancer patients are vulnerable to falls due to muscle loss. In prescribing exercise in a data driven manner to cancer patients, our hypothesis is this "prescription" for exercise will eventually be demonstrated to reduce the occurrence of injurious falls.

Eligibility Criteria

This trial is for cancer patients, except those with non-melanoma skin cancer. Participants should be able to exercise without restrictions like unstable heart conditions or loss of a limb that would make exercising difficult.

Inclusion Criteria

I have been diagnosed with cancer, other than non-melanoma skin cancer.

Exclusion Criteria

I have unstable chest pain.

I have been diagnosed with a type of skin cancer that is not melanoma.

Participant Groups

The study tests an 'exercise prescription' approach using tools like a Perturbation Treadmill, Pedometer, and Actigraph to see if it can reduce falls in high-risk cancer patients by improving muscle strength.

5Treatment groups

Experimental Treatment

Group I: 80%Experimental Treatment3 Interventions

Increase exercise daily step count by 80% above individual baseline.

Group II: 50%Experimental Treatment3 Interventions

Increase exercise daily step count by 50% above individual baseline.

Group III: 30%Experimental Treatment3 Interventions

Increase exercise daily step count by 30% above individual baseline.

Group IV: 20%Experimental Treatment3 Interventions

Increase exercise daily step count by 20% above individual baseline.

Group V: 10%Experimental Treatment3 Interventions

Increase exercise daily step count by 10% above individual baseline.